Circulating TGF-β1 levels have been shown to exhibit dependency on both intermittent hypoxia and obesity (mediated through serum leptin levels)19,21–23, and such observations lead to the question whether OSA may have any effect on the activation of the TGF-β1/SMAD pathway in patients with melanoma, and if so, whether there is any synergistic effect with obesity. This evidence concerns the gene TGFB1 and melanoma.